International Edition
Latest News
Health

Dr. Girish Bathina Explains Continuous Glucose Monitoring and Who Needs It

“Continuous glucose monitoring is a device that measures glucose in the fluid under the skin. It uses a sensor, usually placed on the upper arm or abdomen, to take glucose readings every few minutes. The sensor sends those…

Non-Diabetics Are Using Continuous Glucose Monitors: Is It Necessary? Doctor Answers

“Continuous glucose monitoring is a device that measures glucose in the fluid under the skin. It uses a sensor, usually placed on the upper arm or abdomen, to take glucose readings every few minutes. The sensor sends those readings to a receiver or smartphone so the user can see glucose levels all day long,” said Dr. Girish Bathina, a general medicine consultant at Manipal Hospital in Vijayawada, in an interview with Hindustan Times.

The technology, which uses a sensor to transmit readings to a smartphone every few minutes, is moving beyond intensive insulin therapy into the hands of people without diabetes, prompting clinicians to define where the data helps and where it creates noise.

CGM replaces intermittent finger‑prick checks with a stream of values taken from interstitial fluid. The sensor, typically worn on the upper arm or abdomen, reveals trends — rapid rises after meals, overnight lows, exercise‑driven drops — that single measurements miss. Dr. Bathina shared that the readout allows a patient and physician to see how the body reacts to real‑life scenarios and to catch high‑ and low‑sugar episodes that might otherwise stay hidden.

The devices are best established for people with Type 1 diabetes, those on multiple daily insulin injections, patients who experience frequent hypoglycemia, and those who have lost the ability to feel low‑sugar symptoms, according to Dr. Bathina. Some people with Type 2 diabetes on insulin or unable to reach glucose targets may also benefit, he stated, while those managing Type 2 with diet, exercise or non‑insulin medicines and stable readings can usually stay with occasional finger‑prick tests as advised by a doctor.

Dr. Bathina pointed out that CGM does not fully eliminate finger pricks. Because the sensor measures glucose in fluid between cells rather than in blood, a lag appears when levels change quickly. He said that if symptoms do not match CGM readings, a finger‑prick test may still be needed.

Outside diabetes care, the monitors are being marketed to health‑conscious consumers. NDTV reported that growing awareness of metabolic health is driving non‑diabetics to use CGM to observe how meals, sleep, stress and exercise shift their glucose patterns.

Dr. Manisha Arora, director of internal medicine at CK Birla Hospital in Delhi, told NDTV the devices can offer useful insights in selected cases but are not necessary for everyone.

For most healthy people without diabetes, standard tests — fasting glucose, post‑meal glucose and HbA1c — remain the established way to check blood sugar, Arora said. “Generally speaking, regular CGM use is not required for healthy people who do not have diabetes,” she told NDTV. She warned that a temporary rise after eating does not automatically signal a metabolic problem and that viewing every spike as a warning can create unnecessary anxiety.

Dr. Arora explained that CGM cannot deliver a complete picture of metabolic health on its own because readings are affected by sensor inaccuracies, the physiological delay between blood and interstitial fluid, and individual variation.

“Glucose level changes during the day are typical, and spikes in blood sugar levels after meals do not necessarily mean that metabolic problems exist,” she told NDTV. Diagnosis of diabetes or pre‑diabetes still requires conventional laboratory tests and clinical assessment.

There are scenarios where a doctor may consider CGM for a non‑diabetic patient. Arora told NDTV that in specified cases — particularly for people with risk factors for metabolic disorders — the monitor may help gain insight into individual glucose patterns alongside medical history and other results.

She recommended such monitoring be done under specialist guidance to prevent misinterpretation of short‑term fluctuations.

One potential benefit for non‑diabetics is behavioral. NDTV reported that seeing real‑time data can make people more aware of how everyday choices affect glucose, though Arora cautioned that the information must be interpreted carefully rather than viewed in isolation.

Dr. Bathina emphasized that CGM numbers must be read correctly and used to guide proper treatment by a doctor.

About the author: Health Desk

Health Desk at Archynewsy.